NASDAQ:RLAY | Free Cash Flow | Relay Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$51.11M
2025-12-31-$44.87M$1,000.00-$44.87M
2025-03-31-$73.21M$384,000.00-$73.59M
2024-12-31-$57.87M$0.00-$57.87M
2024-03-31-$50.32M$1.78M-$52.1M
2023-12-31-$89.19M$118,000.00-$89.31M
2023-03-31-$67.13M$1.92M-$69.05M
2022-12-31-$57.08M$2.32M-$59.4M
2022-03-31-$49.17M$2.79M-$51.97M
2021-12-31-$39.71M$880,000.00-$40.59M
2021-03-31$46.64M$476,000.00$46.16M
2020-12-31-$35.27M$64,000.00-$35.34M-100.17%
2020-03-31-$22.33M$1.02M-$23.35M
2019-12-31-$22.76M$598,000.00-$23.36M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$235.46M$410,000.00-$235.87M
2024-12-31-$249.11M$2.02M-$251.13M
2023-12-31-$300.32M$4.13M-$304.44M
2022-12-31-$229.49M$9.06M-$238.55M
2021-12-31-$74.41M$3.47M-$77.88M
2020-12-31-$102.49M$1.93M-$104.42M
2019-12-31-$66.13M$8M-$74.14M